ArticleInternational journal of clinical oncology2018

The use of neoadjuvant therapy for resectable locally advanced thoracic esophageal squamous cell carcinoma in an analysis of 5016 patients from 305 designated cancer care hospitals in Japan.

Yoichiro Tsukada et al.PubMed ↗Publisher ↗

No numbers read from the abstract.